The latest announcement is out from NetraMark Holdings ( (TSE:AIAI) ).
NetraMark Holdings Inc. has announced significant corporate advancements, including the appointment of Dr. Angelico Carta as Chief Strategy Officer, a collaboration with a top pharmaceutical company to advance treatments for autoimmune disorders, and the addition of P.J. Haley to its Board of Directors to expand its oncology sector presence. The company also reported raising $1.16 million through warrants and stock options, enhancing its financial position to support AI solution development, and extended its agreement with ARU Global Inc. to boost public and investor relations.
More about NetraMark Holdings
NetraMark Holdings Inc. is a leader in generative AI software focused on clinical trial analytics. The company specializes in AI-driven solutions that enhance clinical trials and precision medicine, aiming to empower pharmaceutical companies with advanced insights.
YTD Price Performance: -8.29%
Average Trading Volume: 7,840
Technical Sentiment Consensus Rating: Sell
For an in-depth examination of AIAI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com